All Stories

  1. Mechanisms of liver regeneration and their relevance to steatotic liver disease
  2. Peroxisome Dysfunction and Steatotic Liver Disease
  3. A novel human hepatocyte cell line to study PNPLA3-associated steatotic liver disease
  4. Three-Dimensional Dynamic Cell Models for Metabolic Dysfunction-Associated Steatotic Liver Disease Progression
  5. Effects of iron overload in human joint tissue explant cultures and animal models
  6. A new form of hereditary iron overload unlinked to known hereditary haemochromatosis genes
  7. Gene Variants Implicated in Steatotic Liver Disease: Opportunities for Diagnostics and Therapeutics
  8. Engineering Peptide Inhibitors of the HFE–Transferrin Receptor 1 Complex
  9. Cancer: The role of iron and ferroptosis
  10. Genetic Diagnosis in Hereditary Hemochromatosis: Discovering and Understanding the Biological Relevance of Variants
  11. The effect of the flavonol rutin on serum and liver iron content in a genetic mouse model of iron overload
  12. Iron depletion attenuates steatosis in a mouse model of non-alcoholic fatty liver disease: Role of iron-dependent pathways
  13. In vitro identification and characterisation of iron chelating catechol-containing natural products and derivatives
  14. Biology of the iron efflux transporter, ferroportin
  15. Gender biased neuroprotective effect of Transferrin Receptor 2 deletion in multiple models of Parkinson’s disease
  16. Increased frequency of GNPAT p.D519G in compound HFE p.C282Y/p.H63D heterozygotes with elevated serum ferritin levels
  17. Hepatocyte-specific deletion of peroxisomal protein PEX13 results in disrupted iron homeostasis
  18. Dysregulated hepcidin response to dietary iron in male mice with reduced Gnpat expression
  19. Evidence for dimerization of ferroportin in a human hepatic cell line using proximity ligation assays
  20. Correction to: The potential prognostic utility of salivary galectin-3 concentrations in heart failure
  21. Therapeutic Advances in Regulating the Hepcidin/Ferroportin Axis
  22. The potential prognostic utility of salivary galectin-3 concentrations in heart failure
  23. Signaling pathways regulating hepcidin
  24. Cirrhosis in Hemochromatosis: Independent Risk Factors in 368 HFE p.C282Y Homozygotes
  25. Hemochromatosis: Evaluation of the dietary iron model and regulation of hepcidin
  26. Phenotypic analysis of hemochromatosis subtypes reveals variations in severity of iron overload and clinical disease
  27. Hepatic iron concentration correlates with insulin sensitivity in nonalcoholic fatty liver disease
  28. Evaluation of a bone morphogenetic protein 6 variant as a cause of iron loading
  29. Reversal of end-stage heart failure in juvenile hemochromatosis with iron chelation therapy: a case report
  30. Ferroportin Expression in Adipocytes Does Not Contribute to Iron Homeostasis or Metabolic Responses to a High Calorie Diet
  31. Iron Inhibits the Secretion of Apolipoprotein E in Cultured Human Adipocytes
  32. The relationship between systemic iron homeostasis and erythropoiesis
  33. The liver in regulation of iron homeostasis
  34. The dynamics of hepcidin-ferroportin internalization and consequences of a novel ferroportin disease mutation
  35. GNPAT p.D519G is independently associated with markedly increased iron stores in HFE p.C282Y homozygotes
  36. Reply:
  37. Ironing out Steatohepatitis
  38. Combination curcumin and vitamin E treatment attenuates diet-induced steatosis in Hfe-/- mice
  39. The functional roles of T-cadherin in mammalian biology
  40. Genetic Variants in the BMP6 Pro-Peptide May Not Cause Iron Loading and Should Be Interpreted With Caution
  41. Pocket-sized iron regulators: one size fits all?
  42. Hematopoietic deletion of transferrin receptor 2 in mice leads to a block in erythroid differentiation during iron-deficient anemia
  43. Heterozygous Hfe gene deletion leads to impaired glucose homeostasis, but not liver injury in mice fed a high-calorie diet
  44. Probiotics modify tight-junction proteins in an animal model of nonalcoholic fatty liver disease
  45. Redox cycling metals: Pedaling their roles in metabolism and their use in the development of novel therapeutics
  46. Reply
  47. Iron and non-alcoholic fatty liver disease
  48. Reply
  49. The global prevalence of HFE and non-HFE hemochromatosis estimated from analysis of next-generation sequencing data
  50. Normal systemic iron homeostasis in mice with macrophage-specific deletion of transferrin receptor 2
  51. Next-generation sequencing: Application of a novel platform to analyze atypical iron disorders
  52. Endofin, a novel BMP-SMAD regulator of the iron-regulatory hormone, hepcidin
  53. Reply
  54. Hepcidin: regulation of the master iron regulator
  55. Exome sequencing inHFEC282Y homozygous men with extreme phenotypes identifies aGNPATvariant associated with severe iron overload
  56. Inconsistent hepatic antifibrotic effects with the iron chelator deferasirox
  57. Functional analysis of matriptase-2 mutations and domains: insights into the molecular basis of iron-refractory iron deficiency anemia
  58. Analysis of IL-22 contribution to hepcidin induction and hypoferremia during the response to LPS in vivo
  59. A critical role for murine transferrin receptor 2 in erythropoiesis during iron restriction
  60. Hepatology Clinical
  61. IBD Clinical
  62. Luminal Clinical
  63. Linking hypoxia and iron homeostasis: a ‘plate’ full of factors
  64. Lack of efficacy of mTOR inhibitors and ACE pathway inhibitors as antifibrotic agents in evolving and established fibrosis in Mdr2 −/− mice
  65. Hypoxia induced downregulation of hepcidin is mediated by platelet derived growth factor BB
  66. Parenteral vs. oral iron: influence on hepcidin signaling pathways through analysis of Hfe/Tfr2-null mice
  67. Inside Li
  68. Excess iron modulates endoplasmic reticulum stress-associated pathways in a mouse model of alcohol and high-fat diet-induced liver injury
  69. In Situ Proximity Ligation Assays Indicate That Hemochromatosis Proteins Hfe and Transferrin Receptor 2 (Tfr2) Do Not Interact
  70. IBD Clinical
  71. Luminal Clinical
  72. Author Index
  73. Basic Science Luminal
  74. Motility/Neurogastroenterology
  75. Transthyretin-thyroid hormone internalization by trophoblasts
  76. Iron storage disease in Asia-Pacific populations: The importance of non-HFEmutations
  77. A Corn Oil-Based Diet Protects Against Combined Ethanol and Iron-Induced Liver Injury in a Mouse Model of Hemochromatosis
  78. Centrobin regulates centrosome function in interphase cells by limiting pericentriolar matrix recruitment
  79. Transforming growth factor-β and toll-like receptor-4 polymorphisms are not associated with fibrosis in haemochromatosis
  80. Hepatic Iron Deposition Does Not Predict Extrahepatic Iron Loading in Mouse Models of Hereditary Hemochromatosis
  81. Iron Predicts Tolerance in Liver Transplantation
  82. A novel mouse model of veno-occlusive disease provides strategies to prevent thioguanine-induced hepatic toxicity
  83. Non-HFE Hemochromatosis
  84. The Control of Iron Homeostasis: microRNAS Join the Party
  85. Altered lipid metabolism in Hfe-knockout mice promotes severe NAFLD and early fibrosis
  86. G80S-linked ferroportin disease: Classical ferroportin disease in an Asian family and reclassification of the mutant as iron transport defective
  87. Iron loading and oxidative stress in the Atm-/- mouse liver
  88. Blunted hepcidin response to inflammation in the absence of Hfe and transferrin receptor 2
  89. Syntaxin 5 Is Required for Copper Homeostasis in Drosophila and Mammals
  90. Transferrin Receptor 1: A Ferritin Receptor as Well?
  91. Increased Iron Stores Correlate with Worse Disease Outcomes in a Mouse Model of Schistosomiasis Infection
  92. Centrobin regulates the assembly of functional mitotic spindles
  93. Identification of Ferritin Receptors: Their Role in Iron Homeostasis, Hepatic Injury, and Inflammation
  94. Functional analysis and theoretical modeling of ferroportin reveals clustering of mutations according to phenotype
  95. Combined deletion of Hfe and transferrin receptor 2 in mice leads to marked dysregulation of hepcidin and iron overload
  96. Hepcidin Regulation by HFE and TFR2: Is It Enough to Give a Hepatocyte a Complex?
  97. Co-factors in liver disease: The role of HFE-related hereditary hemochromatosis and iron
  98. Carrier-Mediated Thyroid Hormone Transport into Placenta by Placental Transthyretin
  99. Regulation of Iron Homeostasis: Is It All in the HBD?
  100. Juvenile iron overload—Advances, but no answers
  101. Serum hyaluronic acid with serum ferritin accurately predicts cirrhosis and reduces the need for liver biopsy in C282Y hemochromatosis
  102. Lymphotoxin-β receptor signaling regulates hepatic stellate cell function and wound healing in a murine model of chronic liver injury
  103. Kupffer cells modulate iron homeostasis in mice via regulation of hepcidin expression
  104. How much iron is too much?
  105. Defective trafficking and localization of mutated transferrin receptor 2: implications for type 3 hereditary hemochromatosis
  106. A novel mutation in ferroportin implicated in iron overload
  107. [119] TARGETED DISRUPTION OF THE HEPATIC TRANSFERRIN RECEPTOR 2 GENE IN MICE LEADS TO IRON OVERLOAD
  108. Targeted Disruption of the Hepatic Transferrin Receptor 2 Gene in Mice Leads to Iron Overload
  109. Non-HFE haemochromatosis
  110. The Clinical Relevance of Compound Heterozygosity for the C282Y and H63D Substitutions in Hemochromatosis
  111. Clinical expression of C282Y homozygous HFE haemochromatosis at 14 years of age
  112. Screening for Hemochromatosis in Asymptomatic Subjects With or Without a Family History
  113. Purification and partial characterisation of recombinant human hepcidin
  114. Prohepcidin localises to the Golgi compartment and secretory pathway in hepatocytes
  115. Ferroportin disease due to the A77D mutation in Australia
  116. First phenotypic description of transferrin receptor 2 knockout mouse, and the role of hepcidin
  117. Identification of ferroportin disease in the Indian subcontinent
  118. Mammalian Bet3 functions as a cytosolic factor participating in transport from the ER to the Golgi apparatus
  119. HFE gene and hemochromatosis
  120. Autosomal dominant iron overload due to a novel mutation of ferroportin1 associated with parenchymal iron loading and cirrhosis
  121. Reply
  122. Inactivation of the murineTransferrin Receptor 2 gene using the Cre recombinase:LoxP system
  123. Ironing out doxorubicin-related cardiotoxicity
  124. A novel mutation in ferroportin1 is associated with haemochromatosis in a Solomon Islands patient
  125. Disrupted hepcidin regulation in HFE-associated haemochromatosis and the liver as a regulator of body iron homoeostasis
  126. Novel mutation in ferroportin1 is associated with autosomal dominant hemochromatosis
  127. Frequency of the S65C mutation of HFE and iron overload in 309 subjects heterozygous for C282Y
  128. Molecular and Cellular Characterization of Transferrin Receptor 2
  129. Role of p97 and Syntaxin 5 in the Assembly of Transitional Endoplasmic Reticulum
  130. Haemochromatosis in the new millenium
  131. cDNA Characterization and Chromosomal Mapping of Human Golgi SNARE GS27 and GS28 to Chromosome 17
  132. GS32, a Novel Golgi SNARE of 32 kDa, Interacts Preferentially with Syntaxin 6
  133. A Novel Synaptobrevin/VAMP Homologous Protein (VAMP5) Is Increased during In Vitro Myogenesis and Present in the Plasma Membrane
  134. A 29-Kilodalton Golgi SolubleN-Ethylmaleimide-sensitive Factor Attachment Protein Receptor (Vti1-rp2) Implicated in Protein Trafficking in the Secretory Pathway
  135. Endobrevin, a Novel Synaptobrevin/VAMP-Like Protein Preferentially Associated with the Early Endosome
  136. The Mammalian Protein (rbet1) Homologous to Yeast Bet1p Is Primarily Associated with the Pre-Golgi Intermediate Compartment and Is Involved in Vesicular Transport from the Endoplasmic Reticulum to the Golgi Apparatus
  137. N-Ethylmaleimide-sensitive Factor (NSF) and  -Soluble NSF Attachment Proteins (SNAP) Mediate Dissociation of GS28-Syntaxin 5 Golgi SNAP Receptors (SNARE) Complex
  138. GS15, a 15-Kilodalton Golgi SolubleN-Ethylmaleimide-sensitive Factor Attachment Protein Receptor (SNARE) Homologous to rbet1
  139. GS28, a 28-Kilodalton Golgi SNARE That Participates in ER-Golgi Transport
  140. cDNA Cloning and Characterization of Rat Salivary Glycoproteins. Novel Members of the Proline-Rich-Protein Multigene Families
  141. cDNA Cloning and Characterization of Rat Salivary Glycoproteins. Novel Members of the Proline-Rich-Protein Multigene Families
  142. cDNA Cloning and Characterization of Rat Salivary Glycoproteins. Novel Members of the Proline-Rich-Protein Multigene Families